Metabolic effects and the methylenetetrahydrofolate reductase (MTHFR) polymorphism associated with neural tube defects in southern Brazil

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 70, Issue 7, 2004, Pages 459-463

  Félix, Têmis Maria ^a,b   Leistner, Sandra ^a   Giugliani, Roberto ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

1298A>C; 677C>T; Folate; Homocysteine; Methylenetetrahydrofolate reductase; MTHFR; Neural tube defects; Vitamin B12

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE;

ADOLESCENT; ADULT; ARTICLE; BRAZIL; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; CYANOCOBALAMIN DEFICIENCY; FEMALE; FOLIC ACID BLOOD LEVEL; FOLIC ACID DEFICIENCY; GENE; GENETIC POLYMORPHISM; HUMAN; HYPERHOMOCYSTEINEMIA; MALE; METABOLIC DISORDER; MTHFR GENE; NEURAL TUBE DEFECT; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK FACTOR;

ADOLESCENT; ADULT; BRAZIL; CHILD; CHILD, PRESCHOOL; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; INFANT; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); NEURAL TUBE DEFECTS; POLYMORPHISM, GENETIC; VITAMIN B 12;

EID: 3242881463     PISSN: 15420752     EISSN: None     Source Type: Journal    
DOI: 10.1002/bdra.20011     Document Type: Article

References (35)

1. Arruda VR, Siqueira LH, Gonçalves MS, et al. 1998. Prevalence of the mutation C677→T in the methylene tetrahydrofolate reductase gene among distinct ethnic groups in Brazil. Am J Med Genet 78:332-335.
2. Berry RJ, Li Z, Erickson JD, et al. 1999. Prevention of neural-tube defects with folic acid in China. China-US Collaborative Project for Neural Tube Defect Prevention. N Engl J Med 341:1485-1490.
3. Botto LD, Yang Q. 2000. 5,10, methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am J Epidemiol 151:862-877.
4. Brönstrup A, Hages M, Prinz-Langenohl R, Pietrzik K. 1998. Effects of folic acid and combinations of folic acid and vitamin B12 on plasma homocysteine concentrations in healthy, young women. Am J Clin Nutr 68:1104-1110.
5. Castilla EE, Orioli IM. 1985. Epidemiology of neural tube defects in South America. Am J Med Genet 22:695-702.
6. Christensen B, Arbour L, Tran P, et al. 1999. Genetic polymorphisms in methylenetetrahydrofolate reductase and methionine synthase, folate levels in red blood cells, and risk of neural tube defects. Am J Med Genet 84:151-157.
7. Cunha ALA, Hirata MH, Kim CA, et al. 2002. Metabolic effects of C677T and A1298C mutations at the MTHFR gene in Brazilian children with neural tube defects. Clin Chim Acta 318:139-143.
8. Czeizel AE, Dudás I. 1992. Prevention of the first occurrence of neural tube defects by periconceptional vitamin supplementation. N Engl J Med 327:1832-1835.
9. Epeldegui M, Peña-Melian A, Varela-Moreiras G, Pérez- Miguelsanz J. 2002. Homocysteine modifies development of neurulation and dorsal root ganglia in chicks embryos. Teratology 65:171-179.
10. Frosst P, Blom HJ, Milos R, et al. 1995. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10:111-113.
11. Gardiki-Kouidou P, Seller MJ. 1988. Amniotic fluid folate, vitamin B12 and transcobalamins in neural tube defects. Clin Genet 33:441-448.
12. Harmon DL, Woodside JV, Yarnell JWG, et al. 1996. The common "thermolabile" variant of methylenetetrahydrofolate reductase is a major determinant of mild hyperhomocysteinemia. QJM 89:571-577.
13. Kirke PN, Molloy AM, Daly LE, et al. 1993. Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects. Q J Med 86:703-708.
14. Leclerc D, Campeau E, Goyette P, et al. 1996. Human methionine synthase: cDNA cloning, chromosomal localization, and identification of mutations in patients of the cblG complementation group of folate/cobalamin disorders. Hum Mol Genet 5:1867-1874.
15. Leclerc D, Wilson A, Dumas R, et al. 1998. Cloning and mapping of a cDNA for methionine synthase reductase, a flavoprotein defective in patients with homocystinuria. Proc Natl Acad Sci USA 95:3059-3064.
16. Lucock M, Daskalakis L, Hinkins M, Yates Z. 2001. An examination of polymorphic genes and folate metabolism in mothers affected by spina bifida pregnancy. Mol Genet Metab 73:322-332.
17. Medical Research Council Vitamin Study Research Group. 1991. Prevention of neural tube defects: result of the medical research council vitamin study. Lancet 338:131-137.
18. Miller AS, Dykes DD, Polesky HF. 1988. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215.
19. Mills JL, McPartlin JM, Kirke PP, et al. 1995. Homocysteine metabolism in pregnancies complicated by neural tube defects. Lancet 345:149-151.
20. Morrison K, Papapetrou C, Hol FA, et al. 1998. Susceptibility to spina bifida; an association study of five candidate genes. Ann Hum Genet 62:379-396.
21. Mutchinick OM, Lopez MA, Luna L, Waxman J, Babinsky VE. 1999. High prevalence of the thermolabile methylenetetrahydrofolate reductase variant in Mexico: a country with a very high prevalence of neural tube defects. Mol Genet Metab 68:461-467.
22. Perez ABA, D'Almeida V, Vergani N, et al. 2003. Methylenetetrahydrofolate reductase (MTHFR): incidence of mutations C677T and A1298C in Brazilian population and its correlation with plasma homocysteine levels in spina bifida. Am J Med Genet 119A:20-25.
23. Rady PL, Tyring SK, Hudnall SD, et al. 1999. Methylenetetrahydrofolate reductase (MTHFR): the incidence of mutations C677T and A1298C in the Ashkenazi Jewish population. Am J Med Genet 86:380-384.
24. Smithells RW, Sheppard S, Schorah CJ, et al. 1980. Possible prevention of neural tube defects by periconceptional vitamin supplementation. Lancet 1:339-340.
25. Spotila LD, Jacques PF, Berger PB, et al. 2003. Age dependence of the influence of methylenetetrahydrofolate reductase genotype on plasma homocysteine level. Am J Epidemiol 158:871-877.
26. Steegers-Theunissen RPM, Boers GHJ, Trijbels FJM, et al. 1994. Maternal hyperhomocysteinemia: a risk factor for neural tube defects? Metabolism 43:1475-1480.
27. Steen MT, Boddie AM, Fisher AJ, et al. 1998. Neural-tube defects are associated with low concentrations of cobalamin (vitamin B12) in amniotic fluid. Prenat Diagn 18:545-555.
28. Van der Put NMJ, Steegers-Theunissen RPM, Frosst P, et al. 1995. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 346:1070-1071.
29. Van der Put NMJ, van der Molen EF, Kluijtmans LAJ, et al. 1997. Sequence analysis of the coding region of human methionine synthase: relevance to hyperhomocysteinaemia in neural-tube defects and vascular disease. QJM 90:511-517.
30. Van der Put NMJ, Gabreëls F, Stevens EMK, et al. 1998. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural tube defects? Am J Hum Genet 62:1044-1051.
31. Villarreal LEM, Delgado-Enciso I, Valdéz-Leal R, et al. 2001. Folate levels and N5, N10-methylenetetrahydrofolate reductase genotype (MTHFR) in mothers of offspring with neural tube defects: a case-control study. Arch Med Res 32:277-282.
32. Wenstrom KD, Johanning GL, Owen J, et al. 2000. Amniotic fluid homocysteine levels, 5,10-methylenetetrahydrofolate reductase genotypes, and neural tube closure sites. Am J Med Genet 90:6-11.
33. Whitehead AS, Gallagher P, Mills JL, et al. 1995. A genetic defect in 5,10 methylenetetrahydrofolate reductase in neural tube defects. QJM 88:763-766.
34. Wild J, Seller MJ, Schorah CJ, Smithells RW. 1994. Investigation of folate intake and metabolism in women who have two pregnancies complicated by neural tube defects. Br J Obstet Gynaecol 101:197-202.
35. Wilson A, Platt R, Wu Q, et al. 1999. A common variant in methionine synthase reductase combined with low cobalamin (vitamin B12) increased risk for spina bifida. Mol Genet Metab 67:317-323.